Bioxytran, Inc financial data

Symbol
BIXT on OTC
Location
C/O Bioxytran, Inc., 75 2 Nd Ave, Suite 605 Ste 605, Needham, MA
State of incorporation
NV
Fiscal year end
December 31
Former names
U.S. RARE EARTH MINERALS, INC. (to 10/30/2018), U.S. RARE EARTH MINERALS, INC (to 10/3/2018), U.S. Natural Nutrients & Minerals, Inc. (to 4/14/2011), AMERICA'S DRIVING RANGES, INC. (to 10/29/2009)
Latest financial report
10-Q - Q3 2024 - Oct 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.23 % -72%
Debt-to-equity -116 % +3.68%
Return On Equity 179 % +31.5%
Return On Assets -2.04K % -15.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85.8M shares -40.7%
Common Stock, Shares, Outstanding 82.2M shares -43%
Entity Public Float 9.2M USD -11.4%
Common Stock, Value, Issued 82.2K USD -43%
Weighted Average Number of Shares Outstanding, Basic 126M shares -7.37%
Weighted Average Number of Shares Outstanding, Diluted 126M shares -7.37%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 51K USD -83.9%
General and Administrative Expense 2.08M USD +7.23%
Operating Income (Loss) -2.77M USD +22.9%
Nonoperating Income (Expense) -174K USD +76.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.84M USD +33.1%
Net Income (Loss) Attributable to Parent -2.81M USD +32%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 34.7K USD -56.8%
Intangible Assets, Net (Excluding Goodwill) 68.3K USD +261%
Assets 159K USD -15.9%
Accounts Payable, Current 201K USD
Liabilities, Current 1.24M USD -46.7%
Liabilities 1.24M USD -46.7%
Retained Earnings (Accumulated Deficit) -18.3M USD -25.8%
Stockholders' Equity Attributable to Parent -4.76M USD -264%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -1.08M USD +49.4%
Liabilities and Equity 159K USD -15.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -75.6K USD +59.6%
Net Cash Provided by (Used in) Financing Activities 65.5K USD +31%
Net Cash Provided by (Used in) Investing Activities -6K USD -27.3%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 82.2M shares -43%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 52.4K USD
Deferred Tax Assets, Valuation Allowance 2.84M USD +45.8%
Deferred Tax Assets, Gross 2.84M USD +45.8%
Deferred Tax Assets, Operating Loss Carryforwards 13.5M USD +45.8%
Preferred Stock, Shares Issued 28.9M shares
Preferred Stock, Shares Authorized 50M shares 0%
Additional Paid in Capital 16.4M USD +45.2%
Preferred Stock, Shares Outstanding 28.9M shares
Amortization of Intangible Assets 8.86K USD +63.6%
Interest Expense 1.98M USD +99.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%